Genovis AB (publ.) (STO:GENO)
27.00
+0.35 (1.31%)
Jun 17, 2025, 11:47 AM CET
Genovis AB (publ.) Revenue
Genovis AB (publ.) had revenue of 32.61M SEK in the quarter ending March 31, 2025, a decrease of -18.59%. This brings the company's revenue in the last twelve months to 123.87M, down -3.11% year-over-year. In the year 2024, Genovis AB (publ.) had annual revenue of 131.32M, down -17.44%.
Revenue (ttm)
123.87M
Revenue Growth
-3.11%
P/S Ratio
14.08
Revenue / Employee
3.75M
Employees
32
Market Cap
1.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 131.32M | -27.75M | -17.44% |
Dec 31, 2023 | 159.07M | 55.51M | 53.60% |
Dec 31, 2022 | 103.56M | 9.89M | 10.55% |
Dec 31, 2021 | 93.68M | 32.65M | 53.49% |
Dec 31, 2020 | 61.03M | 480.58K | 0.79% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.31B |
Getinge AB | 35.57B |
Asker Healthcare Group AB | 15.57B |
Medicover AB | 23.56B |
Camurus AB | 2.04B |
AddLife AB | 10.42B |
Vimian Group AB | 4.24B |
Genovis AB (publ.) News
- 7 months ago - Genovis AB (OSTO:GENO) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus